MedTrace Logo

A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines

NCT00558649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2013-05-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether low dose flu vaccines delivered with microneedles into the skin (intradermally) are effective.

Conditions

  • Influenza, Human

Interventions

BIOLOGICAL

Flu Vaccine (FLUARIX®)

Influenza Virus Vaccine, FLUARIX®, 2006-2007 Formula

Sponsors & Collaborators

  • NanoPass Technologies Ltd

    lead INDUSTRY

Principal Investigators

  • Pierre Van Damme, MD, PhD · Center for the Evaluation of Vaccination, University of Antwerp

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-09-30
Completion
2007-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00558649 on ClinicalTrials.gov